DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Schoenen J, Jacquy J, Lenaerts M.
High-dose power riboflavin as a novel prophylactic antimigraine therapy: results from a double-blind, randomized, placebo-controlled trial.
Cephalalgia 1997;
17: 244.
We do not assume any responsibility for the contents of the web pages of other providers.